Published in J Leukoc Biol on September 01, 1994
Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp Hematol (2008) 1.52
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One (2013) 1.30
Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. J Virol (2012) 1.15
Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction. J Gene Med (2010) 1.02
The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys. J Virol (2013) 0.92
Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity. J Virol (2014) 0.86
Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages. J Biol Chem (2011) 0.84
Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide. Infect Immun (2013) 0.84
The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4. PLoS One (2014) 0.83
Kinetics of human myeloid-derived suppressor cells after blood draw. J Transl Med (2016) 0.79
HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem Cells. Biology (Basel) (2012) 0.77
Inflammatory status of transmigrating primary rat monocytes in a novel perfusion model simulating blood flow. J Neuroimmunol (2013) 0.76
Ugonin U stimulates NLRP3 inflammasome activation and enhances inflammasome-mediated pathogen clearance. Redox Biol (2016) 0.75
A Subset of Protective γ9δ2 T Cells Is Activated by Novel Mycobacterial Glycolipid Components. Infect Immun (2016) 0.75
Effects of Two Fullerene Derivatives on Monocytes and Macrophages. Biomed Res Int (2015) 0.75
Improving the methods for isolation of monocyte and establishing macrophage cell culture in caprine model. Cytotechnology (2014) 0.75
Preparation of purified perikaryal and synaptosomal mitochondrial fractions from relatively small hypothalamic brain samples. MethodsX (2016) 0.75
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection. J Vis Exp (2015) 0.75
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A (1997) 4.20
Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med (1993) 2.76
Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys (1995) 1.58
Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4-A resolution. J Biol Chem (2001) 1.49
MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44
Molecular cloning and expression of a chloride ion channel of cell nuclei. J Biol Chem (1997) 1.41
The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol (1985) 1.39
Microplate reader-based quantitation of collagens. Anal Biochem (1992) 1.34
Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol (2001) 1.20
Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques (2002) 1.18
Comparison of direct and indirect arterial pressure measurements in hospitalized patients. Aust N Z J Med (1974) 1.15
The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab (2000) 1.12
The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle. J Physiol (2000) 1.09
Interaction of immune and connective tissue cells: I. The effect of lymphokines and monokines on fibroblast growth. J Leukoc Biol (1990) 1.09
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. Br J Cancer (2010) 1.07
The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J (2000) 1.05
The role of alpha 1 protease inhibitor (alpha 1 antitrypsin) in the regulation of immunologic and inflammatory reactions. Aust N Z J Med (1980) 1.03
Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect Immun (1984) 1.01
Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states. Br J Pharmacol (1999) 1.00
Monocyte proliferation in a cytokine-free, serum-free system. J Immunol Methods (1992) 0.99
Functional characterization of the NCC27 nuclear protein in stable transfected CHO-K1 cells. FASEB J (2000) 0.99
Both in vitro and in vivo irradiation are associated with induction of macrophage-derived fibroblast growth factors. Clin Exp Immunol (1996) 0.99
The effect of alpha 1 antitrypsin on the proliferative response of human peripheral blood lymphocytes. J Immunol (1983) 0.98
Alternative hypothesis for efficacy of macrolides in acute coronary syndromes. Lancet (1998) 0.98
Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-RNP IgG. Clin Exp Immunol (1991) 0.97
Blockade by N-3 polyunsaturated fatty acid of the Kv4.3 current stably expressed in Chinese hamster ovary cells. Br J Pharmacol (1999) 0.96
Radiation-induced lung injury: a hypersensitivity pneumonitis? Ann Intern Med (1988) 0.94
Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha. Clin Exp Immunol (1991) 0.93
Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. Placenta (2003) 0.92
The heart of psychotropic drug therapy. Lancet (2000) 0.91
Inhibition of HERG potassium channels by the antimalarial agent halofantrine. Br J Pharmacol (2000) 0.89
In vitro replication dynamics of human culture-derived macrophages in a long term serum-free system. J Immunol (1993) 0.89
Structure of human CLIC3 at 2 A resolution. Proteins (2010) 0.87
Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel. Cardiovasc Res (2000) 0.87
Immunogenetic factors in inflammatory eye disease. Influence of HLA-B27 and alpha 1-antitrypsin phenotypes on disease expression. Arthritis Rheum (1982) 0.86
Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities. Biochemistry (2001) 0.85
Human macrophages contain a stretch-sensitive potassium channel that is activated by adherence and cytokines. J Membr Biol (1995) 0.85
A potassium ion channel is involved in cytokine production by activated human macrophages. Clin Exp Immunol (2002) 0.85
Flow cytometry with crystal violet to detect intracytoplasmic fluorescence in viable human lymphocytes. Demonstration of antibody entering living cells. J Immunol Methods (1987) 0.85
Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization. Clin Exp Immunol (1993) 0.84
Expression of a TGF-beta superfamily protein, macrophage inhibitory cytokine-1, in the yeast Pichia pastoris. Gene (2000) 0.82
The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. J Biol Chem (2001) 0.82
Immunoregulation by alpha 1 antitrypsin. J Clin Lab Immunol (1982) 0.82
Changes in epithelial lining fluid albumin associated with smoking and interstitial lung disease. Eur Respir J (1993) 0.81
Interstitial lung disease associated with connective tissue diseases. The use of statistical structure analysis in model development. Am Rev Respir Dis (1991) 0.81
Inhibition of HERG channels stably expressed in a mammalian cell line by the antianginal agent perhexiline maleate. Br J Pharmacol (1999) 0.81
Response of microvascular endothelial cells to biological response modifiers. Immunol Cell Biol (1989) 0.80
Alpha 1 antitrypsin serum levels and phenotypes in patients with retinal vasculitis. Br J Ophthalmol (1985) 0.79
Analysis of dendritic cell populations using a revised histological staging of morphoea. Br J Dermatol (2000) 0.79
The effect of alpha 1 antitrypsin on phagocyte function. J Clin Lab Immunol (1983) 0.78
Clozapine and sudden death. J Clin Psychopharmacol (2001) 0.78
Identification of macrophage activation associated proteins by two-dimensional gel electrophoresis and microsequencing. J Leukoc Biol (1995) 0.78
Quantitative pulmonary gallium scanning in interstitial lung disease. Eur J Nucl Med (1992) 0.78
Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay. Pathology (2015) 0.77
Bronchoalveolar lavage cellularity: the distribution in normal volunteers. Am Rev Respir Dis (1993) 0.77
Antibodies to tubulin and actin bind to the surface of a human monocytic cell line, U937. J Histochem Cytochem (1991) 0.77
Screening procedure for Pichia pastoris clones containing multiple copy gene inserts. Biotechniques (1999) 0.77
Genetic study of a family with two members with Weber Christian disease (panniculitis) and alpha 1 antitrypsin deficiency. Am J Med Genet (1982) 0.77
Hypoxia during bronchoalveolar lavage. Aust N Z J Med (1990) 0.76
Fibroblast growth factors in connective tissue disease associated interstitial lung disease. Clin Exp Immunol (1992) 0.75
Aspects of the clinical trials of slow-acting anti-rheumatic drugs. Agents Actions Suppl (1988) 0.75
The role of bronchoalveolar lavage in the assessment of diffuse lung diseases. Aust N Z J Med (1989) 0.75
Hypothesis: lymphocyte trafficking in inflammatory rheumatic disease. A role for receptor mediated homing. J Rheumatol (1987) 0.75
Mitotic activity in the dermis of mice during graft versus host disease: the role of fibroblast replication in dermal fibrosis. J Invest Dermatol (1992) 0.75
The differing patterns of interstitial lung involvement in connective tissue diseases. J Rheumatol (1992) 0.75
The effect of purified alpha 1 antitrypsin on PWM driven IgG synthesis. J Clin Lab Immunol (1984) 0.75
Scleroderma lung disease: appropriate management. BioDrugs (1997) 0.75
Restoring antibody activity of a monoclonal anti-RNP antibody by dissociative HPLC. Demonstration of blocking antibody binding sites with antigen released from effete hybridoma cells. J Immunol Methods (1992) 0.75
Recurrent fever in Sjøgren's syndrome. Med J Aust (1989) 0.75